Page last updated: 2024-11-10

carbonyl 3-chlorophenylhydrazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

carbonyl 3-chlorophenylhydrazone: inhibitor of ATP synthesis; inhibits iron-containing nitrile hydratases [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3080694
SCHEMBL ID15515688
MeSH IDM0190967

Synonyms (8)

Synonym
formaldehyde, (3-chlorophenyl)hydrazone
ccpho
3-chloro-n-(methylideneamino)aniline
carbonyl m-chlorophenylhydrazone
carbonyl 3-chlorophenylhydrazone
14046-96-9
SCHEMBL15515688
DTXSID20161405

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Here, we endeavoured to review and discuss the characteristics of nanoparticles relevant to their toxicity, conceivable exposure routes of nanoparticles to human body like skin contact, inhalation, and ingestion, and the basic approaches which can aid to control human exposures to toxic nanoparticles have been discussed."( Safety issues associated with the use of nanoparticles in human body.
Khattak, JZK; Rana, MS; Sufian, MM; Yousaf, S, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (6.67)18.2507
2000's14 (31.11)29.6817
2010's22 (48.89)24.3611
2020's6 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.08 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index46.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]